Summary
This prediction ended on 10.12.23 with a price of €30.20. During the runtime of the prediction for Genmab As the price only changed by 0.67%. melinda has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Genmab As | 1.613% | 1.613% | 26.633% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |